Zentrum fuer Forschungsfoerderung in der Paediatrie
Zentrum fuer Forschungsfoerderung in der Paediatrie is recorded as a service provider in 7 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 7 of 7 trials · Latest update first
ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) with Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Sponsor Karolinska University Hospital
- Start (EU)
- Latest update
- Estimated end
Revumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
Sponsor Pediatric Research International GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomized multi-centre open-label non-inferiority phase 3 clinical trial for patients with a stage IV childhood renal tumour comparing upfront Vincristine, Actinomycin-D and Doxorubicin (VAD, standard arm) with upfront Vincristine, Carboplatin and Etoposide (VCE, experimental arm)
Sponsor GPOH gGmbH
- Start (EU)
- Latest update
- Estimated end
Safety and efficacy of steering of immunosuppression based on BKPyV-specific T cells in case of BK Polyomavirus (BKPyV) DNAe- mia after kidney transplantation
Sponsor Paediatrisches Forschungsnetzwerk gGmbH
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
International open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide in pediatric, adolescent, and adult patients with GD2-positive Ewing sarcoma
Sponsor GPOH gGmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents
Sponsor GPOH gGmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Comparison of neurocognitive outcome in two standard regimen for treatment of low-risk medulloblastoma (COGNITO-MB)
Sponsor GPOH gGmbH
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Zentrum fuer Forschungsfoerderung in der Paediatrie?
The 2026-10-09 snapshot links Zentrum fuer Forschungsfoerderung in der Paediatrie to 7 distinct CTIS trials. Recorded services include Clinical monitoring, Regulatory services, Safety reporting & pharmacovigilance, Data management, among 8 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Zentrum fuer Forschungsfoerderung in der Paediatrie?
The most frequently recorded therapeutic areas are Haematological Malignancies, Solid Tumor Oncology, Urology. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Zentrum fuer Forschungsfoerderung in der Paediatrie conducted?
The linked trials record locations in 20 countries, including Germany, Austria, Czechia, Denmark, Netherlands. These are trial locations, not confirmed office locations or countries where Zentrum fuer Forschungsfoerderung in der Paediatrie delivered services.
What can this page tell me about Zentrum fuer Forschungsfoerderung in der Paediatrie's trial experience?
Browse 7 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Zentrum fuer Forschungsfoerderung in der Paediatrie. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Zentrum fuer Forschungsfoerderung in der Paediatrie GmbH